how-to-patent-in-europe-epo 
IP Watchdog
JUNE 19, 2023
The impact of the long-awaited launch of the Unified Patent Court (UPC) is hard to overstate. While litigators and patent portfolio managers are immediately feeling the impact in Europe, surprisingly, they should also expect an impact on information disclosure statement (IDS) strategy for U.S. patent applications.
IP Watchdog
SEPTEMBER 5, 2021
In Part I of this series, we discussed how patent portfolio managers should be careful when generating company-owned prior art or reviewing competitor prior art, and how a patent litigation or licensing campaign can be significantly hamstrung based on how the United States and Europe consider intervening prior art.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The IPKat
JANUARY 5, 2022
The EPO Guidelines for Examination require the description of a patent application to summarise the background art ( F-II-4.3 ). It is hard to see how the addition of a simple summary of the prior art could be detrimental to the patentee. The patent as granted ( EP2657138 ) related to a food product handling system (e.g.
Fish & Richardson Trademark & Copyright Thoughts
JUNE 14, 2022
Moritz Ammelburg and Peter Fasse examine the patentability requirements and prosecution schemes in the US and Europe and how applicants can prepare applications that will best serve their needs in both jurisdictions. can significantly complicate the coordination of a global patent strategy. Inventorship.
The IPKat
DECEMBER 28, 2021
Following on from our IPKat EBA 2021 Year in Review , here is some more festive holiday reading on some of the important decisions to come out of the EPO Boards of Appeal this year. As the year draws to the close, the EPO has announced the Legal Boards of Appeal decision on whether an AI can be named as an inventor (J 8/20 and J 9/20).
SpicyIP
FEBRUARY 4, 2024
In May 2023, the UK Court of Appeal upheld the invalidity of Bristol-Myers Squibb’s Apaxiban patent for lacking “plausibility” But how does this finding interact with the position of relevant laws in India? Amit is a registered Patent Agent and is currently part of IP litigation team at Sun Pharmaceuticals.
The IPKat
DECEMBER 20, 2023
US patent attorneys wishing to understand certain peculiarities of European patent drafting need look no further than the recent Board of Appeal decision in T 2171/21. This case is a textbook example of the EPO's strict approach to added matter. Profanity The patent was opposed for added matter.
Expert insights. Personalized for you.
122 
Let's personalize your content